Background. There is a need for experimental animal models for inflammatory bowel diseases (IBD), but no proposed model has been unanimously accepted.
Introduction
Animal models can be a valuable tool in understanding complex diseases such as ulcerative colitis (UC) and Crohn's disease (CD). Progress in the research for understanding the mucosal inflammation-immune balance of inflammatory bowel disease (IBD) has been delayed by a lack of adequate experimental models. No single IBD model captures the diversity of this human disease, but each of them provides valuable insight into one main feature of IBD or another, and together they contribute to the foundation of a largely accepted set of pathogenetic principles which enhance the current therapeutic approaches to CD and UC. 1 An "IBD integrom" concept offers a solution for a better understanding of the 4 components of pathogenesis, namely, genetic information (the genome); the surrounding environment (the exposome); the gut microbiota variations (the microbiome); and the intestinal immune reactivity (the immunome). 2 Although the immunome is the primary effector arm of inflammation in CD and UC, having been well characterized through the IL-17/ IL-23 axis, other pathogenic processes could be implicated in the first stage of the disease. 3, 4 Intestinal cells die by necrosis and release many molecules which are collectively named damage-associated molecular patterns (DAMPs) -independent of pathogen-associated molecular patterns (PAMPs) -leading to traditional microbial inflammation. 2 The release of DAMPs is intrinsic to IBD; these biological products trigger sterile inflammation in IBD mucosa affected by bleeding or ulcer formation. 5 Moreover, there is a hypothesis that chronic inflammation due to IBD could be a combination of traditional and sterile inflammations which is known as unresolving inflammation. 5 In addition, another process with contrasting results in IBD animal models is the inflammasome pathway mediated by caspase-1 in 2,4,6-trinitrobenzene sulfonic acid-induced colitis. 6, 7 A variety of agents could be used as inducers of colitis: acetic acid, formalin, indomethacin, carrageenan, or immune complexes. 8, 9 The 2 most widely used IBD inducers in rodents are 2, 4, 6-trinitrobenzene sulfonic acid (TNBS) -ethanol administered as an enema -and dextran sulfate sodium (DSS) -often administered orally (although it can also be administered rectally) -which evoke colitis and immune inflammatory responses. [10] [11] [12] The sulfated polysaccharide of DSS is directly toxic to the colonic epithelium. Thus, the short-term addition of DSS to drinking water leads to a very reproducible acute colonic inflammation as well as to a useful model for a better understanding of UC innate immune mechanisms. 1, 13 Intrarectal administration of a TNBS haptenating agent allows the initiation of a transmural colitis which mimics human CD and is useful for cytokine release patterns, effective immunotherapy and for the exploration of mucosal homeostasis. 1, 14 Ample debate still exists as to whether reactive oxygen species (ROS) are involved in the pathogenesis of tissue lesions or are endogenously produced as a consequence of damaged cells. Moreover, in contrast with normal mucosa, significantly elevated concentrations of ROS are found in the actively inflamed mucosa of patients. 15 Extracellular glutathione peroxidase (E-GPx) is a selenoenzyme that reduces organic peroxides, and hydrogen peroxide. 16 GPx activity in humans is attributable to E-GPx. The gastrointestinal (GI) tract also produces and secretes E-GPx into the extracellular environment.
Animal models of IBD remain essential to the proper understanding of the histopathological shift in the GI tract and also play a key role in the development of novel antidotes for IBD. 1, 17, 18 The aim of the study was to reproduce 2 models of IBD in rats in order to evaluate GPx activity during GI tract inflammation and to characterize the morphological changes occurring in the colonic wall. The DSS model could be valuable for the study of human UC, while the TNBS model is important for human CD.
Material and methods
In this experiment, 15 male Wistar rats weighing 200--290 g were used, in accordance with Directive 2010/63/EU of the European Parliament and the Council on the Protection of Animals used for Scientific Purposes. The animals were obtained from the Laboratory Animals Biobase of the University of Agricultural Sciences and Veterinary Medicine from Cluj-Napoca, Romania. They were maintained in a restricted access room and were housed in plastic cages under standard laboratory conditions (room temperature of 22°C, humidity of 50-60%, with a controlled 12-h light/dark cycle). They had free access to standard laboratory rodent formula pellets.
The rats were randomized into 3 groups, with 5 rats in each one. Group 1 received tap water; Group 2 received 5% DSS (MW 5000 Da, Sigma, St. Louis, USA) in their drinking water for 7 days; Group 3 intrarectally received a single dose of 100 mg/kg of TNBS (1 M, 293.17 mg/mL, product No. 92822, Fluka, Buchs, Switzerland) diluted in 50% ethanol to a concentration of 31.25 mg/mL, and had free access to tap water. The total volume instilled varied between 0.64-0.8 mL according to the rats' weight. Under anesthesia (10 mg/kg of xylazine and 100 mg/kg of ketamine, 1 M), the TNBS was instilled into the colon lumen via a polyethylene catheter (3-millimeter outer diameter) fitted onto a 1-milliliter syringe, introduced so that the tip was approx. 10 cm proximal to the anus. After instillation, the rats were held with the head down for 1 min to prevent TNBS from leaking out, and they were maintained in a head-down position at 45° until they recovered from the anesthesia.
The animals were observed daily and checked for fecal consistency. Also, water consumption and weight changes were monitored. On day 8 of the experiment, under deep anesthesia, blood samples were collected by cardiac puncture and all the animals were euthanized. Laparotomy was performed and the colon was removed as a whole and placed in a Petri dish containing a saline solution. The colon length was measured; the total length was calculated from the cecocolic junction to the rectum at the synphisic bone. Then the colon was opened along the mesenteric side and the luminal colonic surface was gently washed with an iso-osmotic saline solution to remove residual luminal content; then it was weighed. It was next immersed in a 10% neutral buffered formalin solution (Chempur, cat. No. 200-001-8, Piekary Śląskie, Poland) for 48 h, then trimmed into 3 equal segments (representing the proximal, middle and distal colon) and processed for routine light microscopy according to standard procedures.
Histopathology
The samples were dehydrated in ethanol baths with ascending concentrations, cleared in xylene and embedded in low-melting-point paraffin wax following routine laboratory protocol. 19 Multiple 4-micron sections were cut from the resulting paraffin blocks and stained with hematoxylin and eosin (H&E). Microscopic images were captured with an Olympus BX41 optical microscope coupled with an Olympus UC30 digital camera (Olympus, Hamburg, Germany). Finally, the images were processed by Stream Basic software (Olympus Soft Imaging Solution GmbH, Münster, Germany).
Histological semiquantitative analysis
The severity of induced colonic inflammation was graded morphologically using a semiquantitative scale by the same histopathologist in a single-blind fashion. We employed the histological scoring system previously described by Rachmilewitz for grading the severity of DSS-and TNBSinduced colitis in rodents. 20 This grading system considers the following 5 structural parameters scored on a scale of 0 to 4: depth and extent of the ulcer, presence of inflammation, extent of inflammation, and location of fibrosis (Table 1) .
GPx activity assay
GPx activity was measured using a RANSEL kit (Randox Laboratories LTD., cat. No. RS504, Crumlin, UK) at 37°C on a Cobas Mira Plus (Roche, Basel, Switzerland) analyzer at 340 nm. The assay is based on the previously described method. 21 
Hemoglobin concentration assay
The hemoglobin (Hb) concentration was determined by the Drabkin method. 22 
Statistical methods
Descriptive and inferential statistics were used in our study. For the statistical analysis of data, R v. 3.2.4 (A Language and Environment for Statistical Computing, R Core Team, R Foundation for Statistical Computing, Vienna, Austria) and STATISTICA v. 6 (StatSoft, Tulsa, USA) software was used. Student's t-test was used and the equality of variances was previously tested by Levene's test. Because multiple groups were compared, the significance level (α) chosen for all independent t-tests was equal to 0.02.
To evaluate the differences in repeated measurements of body weight, we used a paired t-test. Because there were 7 occasions, the significance level was adjusted after a Bonferroni correction, and it was equal to 0.01. The results of the paired t-test were considered significant if p ≤ 0.01.
In order to evaluate the colon length differences in the 3 groups, the Kruskal-Wallis and Mann-Whitney tests were used. Because of the multiple comparisons, the significance level was adjusted after a Bonferroni correction, and it was equal to 0.02. The statistical significance was set at p ≤ 0.02.
The Pearson correlation coefficient (r) was also used to study the degree of correlation between the 2 quantitative variables.
All animal care and experimental protocols used in this study were approved by the Ethics Committee of "Iuliu Haţieganu" University, Cluj-Napoca, Romania (Ethics Committee approval No. 74/20.02.2014). All applicable international, national and/or institutional guidelines for the care and use of animals were followed. The mean colon weight was significantly different (t = −5.25; df = 8; p = 0.001 < 0.02) in the control rats (2.38 g) compared to Group 3 (3.87 g). Mean colon weight values were significantly different (t = −4.61; df = 8; p = 0.002 < 0.02) in the TNBS-treated group (3.87 g) compared to the DSS-treated group (2.52 g).
Next, the differences in colon length in the 3 groups were established. The Kruskal-Wallis test indicated statistically significant differences among the 3 studied groups (χ 2 = 10.25; df = 2; p = 0.006 < 0.05). These statistically significant differences between the colon length (cm) values in Groups 1 and 3 were confirmed by a post-test analysis (Mann-Whitney test; p = 0.019 < 0.02). We observed lower mean colon length levels in the TNBS-treated group compared to the controls (mean rank = 3.40 vs 7.60). Other statistically significant differences between the colon length (cm) values in the TNBS-treated group compared to the DSS-treated group (mean rank = 3 vs 8) were identified and validated by the Mann-Whitney test (p = 0.007 < 0.02).
Results
After DSS or TNBS inoculation, the rats showed differences in colon weight/length, Hb concentration and GPx activity (Table 2 ). In the DSS and TNBS rat models, the whole blood GPx activity was higher compared to the control rats (in accordance with those of other studies), but not statistically significantly higher in the TNBSinoculated rats (Table 1) .
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Comparisons of clinical parameters among the study groups
The Student's t-test for the global comparison of the control and DSS-treated rats indicated statistically significant differences in Hb levels in the 2 groups (t-test assuming unequal variances, t = −2.86; df = 8; p = 0.02). The mean level of Hb concentration was higher (14.32 g/dL) among the DSS-treated group compared to the controls (12.58 g/dL). The mean level of Hb concentration in the DSS-treated group (14.32 g/dL) was significantly higher (t = 4.846; df = 8; p = 0.001 < 0.02) compared to the TNBS group We also established a good negative linear correlation between colon weight and colon length (r = −0.54; p = 0.038 < 0.05).
There were no statistically significant differences in GPx activity between the control group and the DSS group (t = −0.53; df = 8; p = 0.612), between the controls and the TNBS-treated group (t = 0.96; df = 8; p = 0.364), or between DSS-and TNBS-treated groups (t = 1.87; df = 8; p = 0.099).
In the TNBS-treated group, significant differences in body weight were found between the initial level (Wd0) and day 1 (Wd1) (paired-sample t-test, t = 7.55; df = 4; Furthermore, in the TNBS-treated group there were also significant differences between Wd0 and Wd2 (pairedsamples t-test, t = 14; df = 4; p = 0.0001 < 0.01). We observed a lower level of Wd2 (271.60 g) compared to Wd0 (294.60 g). The findings are the same for the 3 rd -and 4 thday body weight measurements ( Fig. 1) .
Macroscopic findings
After the 7-day cycle of DSS administration, the mucosa presented focal congestion and superficial erosions in the middle and distal colon.
At 7 days after TNBS inoculation, we observed diffuse congestion, deep ulcers (single or multiple) -located in the middle and distal colon -multifocal ulcerative colitis, and ulceration areas coated by an adherent fibrinous material. The colon lymph nodes were congested and edematous.
Histological findings
Following the administration of DSS, the colonic mucosa showed multifocal ulcerative colitis-like lesions which tended to occur more in the posterior part of the colon (Fig. 2) . The mucosal erosions were superficial, associated with discrete hyperemia and edema of the lamina propria. The inflammatory infiltrate was diffusely distributed in the mucosa, without any apparent connection to the ulcerative foci. The inflammatory population was discreetly present, being composed by a mixture of polymorphonuclear cells, lymphocytes and plasmocytes. Also, discreet interstitial fibrosis and crypt dilatation were observed.
For the TNBS-induced colitis, the histological changes presented as multifocal areas of ulcerative colitis covered by a mixture of cellular debris, fibrin, blood, and polymorphonuclear cells. The ulcerative lesions were deep, involving the mucosa and submucosa of the colon. The ulcers and associated inflammation frequently displayed a transmural pattern, inducing an overall thickening of the colonic wall. Severe villous atrophy with crypt distortion, polymorphonuclear cells and rare mononuclear leukocytes were observed to infiltrate the lamina propria, the muscularis mucosae and the submucosa (Fig. 3) . Marked fibrosis of the mucosa, with disruption of the muscularis mucosae and extension through the submucosa, accompany the ulcerative process.
Statistically significant differences in the histological score were found. The mean values of histological scores and also the total score were higher in the TNBS group than in the DSS group (Table 3) .
Discussion
Using DSS, a polyanionic derivative of dextran, the induced colonic inflammation starts distally after around 5 days and the lesions are confined to the colonic mucosa. DSS has a direct effect on the inner mucus layer and allows bacteria to penetrate it before any signs of inflammation are observed. 18 DSS colitis is used to explore the role of inflammasome stimulation and Th-17 responses, or dectin receptors and Toll-like-receptor-initiated immune mechanisms. [24] [25] [26] Also, DSS models could serve for the activation of epithelial TLR4 and releasing factors -which have positive effects and reduce the severity of DSS colonic inflammation -as well as for numerous intracellular signaling pathways. 27, 28 The DSS-induced colitis in rodents quantifies the process of colonic cancer in relation to IBD. 29, 30 Using DSS to induce colitis in Wistar rats, Kishimoto et al. mentioned that it was histologically similar to active human ulcerative colitis. 31 After 6 days of 4% DSS administration in Sprague-Dawley rats, Gaudio et al. reported focal erosions of the epithelium with slight crypt dilatation and lesions similar to the ones found in our study. 29 Chen et al. developed a model of colitis in Sprague-Dawley rats using 2% DSS for 3 days followed by an intracolonic administration of 30% ethanol, which produced severe ulceration and inflammation of the distal part of the rat colon, histologically characterized by increased specific infiltration, the presence of cryptic abscesses, and dysplasia. 32 TNBS is a nitroaryl oxidizing acid with extreme oxidizing properties; when dissolved in ethanol, it induces severe colonic necrosis surrounded by acute inflammation areas. TNBS reduces mucosal hydrophobicity by reacting with the surface-active phospholipids of the colonic mucosa, thus inducing colonic inflammation. 1, 33 Ethanol is very commonly used as a "barrier breaker" by increasing mucosal permeability. A failure in this barrier may result in intestinal inflammation, most likely through exposure to fecal antigens. 32 In TNBS-induced colitis in rats, the inflammatory response includes mucosal and submucosal infiltration by lymphocytes, macrophages, polymorphonuclear leukocytes, connective tissue mast cells, and fibroblasts. 34 The TNBS model highlights the fact that the loss of immune tolerance could lead to chronic intestinal inflammation. Moreover, modulation of the regulatory immune cells acts as a potential treatment method for the proper management of inflammatory intestinal disorders. 35 Additionally, this colitis model served as a source of knowledge about the cytokine profile in human IBD and also as a way to treat the disease in humans. Moreover, it continues to be an advantageous platform for studying the fundamental aspects of human IBD in terms of its spontaneous fibrosis and resolution. 1 The activation of the immune system leads to the increased production of proinflammatory cytokines, such as IL-17, TNF-α, IL-1β, IL-6, and IL-21, ROS, and prostaglandins contributing to a chronic inflammatory process. 15 In our study, the lesions produced by TNBS were characterized by a higher histological score for all criteria than the ones generated by DSS; in 4 of the 5 criteria, the histological scores were statistically significant. In the DSS group, the highest histological score (1.6 ±0.89) was recorded for the criterion which described the extent of the ulcer, in most cases with a punctuate aspect. For the TNBS group, the highest histological score (3.2 ±0.44) was recorded for the extent of inflammation, characterized mostly by mucosal/submucosal and muscle involvement. Significantly reduced colon length as a result of muscular contraction compared to controls was also reported by Gaudio et al. in rat experimental colitis after oral DSS administration.
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Conclusions
The experimental DSS-or TNBS-induced bowel inflammation used in this study corresponds to human IBD and is reproducible with characteristics indicative of acute inflammation in the case of the protocols mentioned.
